Here, we summarize the discussions and conclusions from an expert workshop held in October 2012 to consider the implications of HIV drug resistance in the context of scale-up of access to antiretroviral therapy and prophylaxis in resource-limited settings. Topics considered during the workshop included the implications of drug resistance for the selection of irst-line regimens and sequencing of treatments, optimal surveillance strategies and prevention of mother-to-child transmission.

dx.doi.org/10.3851/IMP2650, hdl.handle.net/1765/62927
Antiviral Therapy
This work was funded by the European Commission 7th Framework Programme; grant id fp7/223131 - Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN), This work was funded by the European Commission 7th Framework Programme; grant id fp7/260694 - European Network of HIV/AIDS Cohort Studies to Coordinate at European and International Level Clinical Research on HIV/AIDS (EUROCOORD)
Erasmus MC: University Medical Center Rotterdam

Pillay, D, Deenan, J, Bertagnolio, S, Boucher, C.A.B, Brun-Vézinet, F, Clotet, B, … Perno, C.F. (2013). Implications of HIV drug resistance on first- and second-line therapies in resource-limited settings: Report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network. Antiviral Therapy, 18(6), 831–836. doi:10.3851/IMP2650